Source: GLOBENEWSWIRE

Press Release: Dymedex : New Dymedex Report Shows Resistant Hypertension Patients Are Both Over Treated and Underdiagnosed

Read full article »
Dymedex's Competitors | Dymedex's News | Dymedex's Financials
Stay up-to-date with the latest news on Dymedex
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Joe Galatowitsch's photo - President of Dymedex

President

Joe Galatowitsch

CEO Approval Rating

68/100

Read more
Stay up-to-date with the latest news on Dymedex